ArticleThe Journal of antibiotics2018

Rifaximin decreases virulence of Crohn's disease-associated Escherichia coli and epithelial inflammatory responses.

Belgin Dogan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.